Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.

PubWeight™: 2.00‹?› | Rank: Top 2%

🔗 View Article (PMID 12004349)

Published in Liver Transpl on May 01, 2002

Authors

Sanjiv Saigal1, Suzanne Norris, Paolo Muiesan, Mohamed Rela, Nigel Heaton, John O'Grady

Author Affiliations

1: Institute of Liver Studies, King's College Hospital, London, UK.

Articles citing this

De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45

Post-transplant malignancy in liver transplantation: a single center experience. Medicine (Baltimore) (2014) 1.44

Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet's nest! Gut (2006) 1.26

Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology (2009) 1.18

De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant (2006) 0.99

Liver transplantation. Gut Liver (2009) 0.93

Liver transplantation for alcoholic liver disease. World J Gastroenterol (2010) 0.91

De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant (2013) 0.91

Current status of immunosuppression in liver transplantation. J Clin Exp Hepatol (2013) 0.86

Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86

Donor transmitted and de novo cancer after liver transplantation. World J Gastroenterol (2014) 0.85

Posttransplantation malignancies: a problem, a challenge, and an opportunity. Liver Transpl (2002) 0.82

Long-term survival after liver transplantation for alcoholic liver disease. World J Gastroenterol (2013) 0.81

Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol (2016) 0.78

Challenges in transplantation for alcoholic liver disease. World J Gastroenterol (2014) 0.78

De novo cancers following liver transplantation: a single center experience in China. PLoS One (2014) 0.77

Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis. BMC Cancer (2014) 0.77

Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77

Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis. World J Hepatol (2015) 0.76

Incidence and management of colorectal cancer in liver transplant recipients. Clin Colorectal Cancer (2008) 0.76

Acute myeloid leukemia of a primary hepatic carcinoma patient after liver transplantation: a case report and literature review. Int J Clin Exp Pathol (2015) 0.75

Nephrectomy for a renal metastasis of undiagnosed hepatocellular carcinoma arising from an orthotopic liver transplant undertaken for cryptogenic cirrhosis. Korean J Urol (2013) 0.75

A symptomatic de novo pheochromocytoma 23 years after liver transplantation: a case report and review of the literature. Case Rep Transplant (2014) 0.75

Liver Transplantation for Alcohol-Related Liver Disease. J Clin Exp Hepatol (2016) 0.75

De novo lung cancer diagnosed 32 months after liver transplantation: report of a case. Surg Today (2011) 0.75

Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation (2017) 0.75

Articles by these authors

Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med (2015) 3.47

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet (2014) 3.12

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91

Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81

Providing treatment to prisoners with mental disorders: development of a policy. Selective literature review and expert consultation exercise. Br J Psychiatry (2003) 2.79

Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl (2007) 2.59

Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23

Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis (2003) 2.17

The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1. Clin Infect Dis (2012) 2.16

Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15

Adult-to-adult living donor liver transplant: UK experience. Eur J Gastroenterol Hepatol (2003) 2.05

Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl (2013) 2.05

Increasing burden of liver disease in patients with HIV infection. Lancet (2011) 1.98

Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol (2013) 1.83

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut (2010) 1.83

Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl (2006) 1.82

Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol (2005) 1.79

Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol (2011) 1.74

Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66

Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol (2003) 1.63

One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62

Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl (2005) 1.60

Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol (2003) 1.58

Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transpl (2013) 1.48

Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47

Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47

Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47

Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45

Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45

Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45

Diaphragmatic dysfunction after pediatric orthotopic liver transplantation. Transplantation (2002) 1.43

Death of a living liver donor: opening Pandora's box. Liver Transpl (2013) 1.43

Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42

Live organ-donation for islet transplantation. Lancet (2005) 1.40

Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg (2004) 1.39

Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis (2007) 1.31

Human plasma fibrinogen is synthesized in the liver. Blood (2006) 1.27

Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25

Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. J Hepatol (2002) 1.22

Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry (2008) 1.18

Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18

Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl (2008) 1.15

The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15

Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak. Hepatology (2011) 1.14

Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? Transplantation (2015) 1.13

Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13

Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12

Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem (2005) 1.11

Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl (2006) 1.10

Pseudoaneurysm following laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int (2007) 1.10

Emergency liver transplantation following severe liver trauma. Liver Transpl (2008) 1.09

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08

Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab. Liver Transpl (2005) 1.08

Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Hepatobiliary Pancreat Dis Int (2007) 1.08

Selective embolization for bleeding visceral artery pseudoaneurysms in patients with pancreatitis. Hepatobiliary Pancreat Dis Int (2010) 1.07

The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation (2004) 1.07

How we treat sickle hepatopathy and liver transplantation in adults. Blood (2014) 1.07

Cholangiopathy and the biliary cast syndrome. Eur J Gastroenterol Hepatol (2003) 1.06

Liver transplantation for hepatocellular carcinoma with allografts from donors after circulatory death: is the tumor recurrence genuinely increased? Liver Transpl (2014) 1.06

Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation (2003) 1.06

Upper gastrointestinal bleeding: predictors of risk in a mixed patient group including variceal and nonvariceal haemorrhage. Eur J Gastroenterol Hepatol (2012) 1.04

Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl (2004) 1.04

Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection. Gut (2011) 1.01

Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation. Liver Transpl (2011) 1.01

Graft positioning at liver transplantation in situs inversus. Liver Transpl (2006) 1.01

Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant (2003) 1.00

A preoperative predictive score of pancreatic fistula following pancreatoduodenectomy. HPB (Oxford) (2013) 1.00

Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol (2008) 1.00

Immunosuppression minimization vs. complete drug withdrawal in liver transplantation. J Hepatol (2013) 0.99

Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl (2010) 0.98

Auxiliary liver transplantation for acute liver failure in children. Ann Surg (2010) 0.98

Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet (2005) 0.98